Innovative Approaches to Assessing Thyroid Disruption: The 3D Human Thyroid Microtissue Model

Watch Now

Sponsored by:

LifeNet Health LifeSciences
Date:
May 8, 2024

Webinar Summary

  • Development of the 3D thyroid microtissue model.
  • Evaluation of model performance, including the production of thyroid hormone.
  • Standardization of the model for thyroid disruption testing.

In this webinar, Dr. Deisenroth discusses the US EPA Endocrine Disruptor Screening Program's (EDSP) approach to screen chemicals for potential thyroid-disrupting effects and the urgent need to advance new approach methods that protect human health while reducing animal testing. He showcases how hormone production in the model mimics human endocrine biology and is inhibited following exposure to known reference chemicals that affect key targets within the thyroid gland.

Dr. Deisenroth also explains the methodology behind establishing minimum donor qualification criteria and benchmark parameters for test method standardization, transferability, and validation. This approach balances performance standardization with the ability to predict a range of human responses.

Lindsey Whaley from LifeNet Health then unveils the first primary human thyrocyte product that enables access to the 3D thyroid microtissue model. Join us for a journey into cutting-edge scientific research that promises to reshape how we assess thyroid disruption.

Presenters

Chad Deisenroth

UL Research Institutes' Chemical Insights (Center for Chemical Informatics and Screening)
Principal Laboratory Toxicologist

Dr. Chad Deisenroth is a Principal Laboratory Toxicologist in the Center for Chemical Informatics and Screening at UL Research Institutes' Chemical Insights. He earned his Ph.D. in Genetics and Molecular Biology from the University of North Carolina at Chapel Hill and completed postdoctoral training in chemical safety sciences at The Hamner Institutes for Health Sciences.

Read More

Lindsey Whaley

LifeNet Health (LifeSciences)
Product Manager

As LifeSciences product manager, Lindsey has a passion for driving innovation and delivering exceptional user experiences. Known for her collaborative approach and ability to translate marketing insights into actionable strategies, Lindsey is dedicated to delivering products that align with core customer needs. Lindsey holds a bachelor’s degree in biology and a master’s degree in biotechnology. During her academic journey, she completed two internships at LifeNet Health focused on various LifeSciences marketing projects where she quickly developed a passion for making high-quality, human research solutions accessible to scientific researchers. In her role as Product Manager for LifeNet Health LifeSciences, Lindsey collaborates with cross-functional teams to manage new product releases and an existing portfolio to a global market. She most enjoys using her scientific background to effectively communicate the benefits of LifeSciences’ innovation portfolio to the scientific community.

Read More

Sponsor

LifeNet Health LifeSciences

LifeNet Health LifeSciences leads the way in human in vitro biology for both non-diseased and diseased research needs. LifeNet Health LifeSciences combines innovative, technology-driven research and development programs to create human tissue and cell-based research products and services.

Content Partners

Scientist.com

Scientist.com is the world’s largest and first platform built for the intricacies of scientific outsourcing.

We help pharmaceutical and biotechnology organizations discover, engage, manage, and scale relationships with the providers that support every stage of the pipeline—from discovery and preclinical research to clinical development, manufacturing, medical affairs, and commercialization. Through a centralized platform, organizations can access a global network of 6,000+ providers, streamline sourcing and procurement workflows, maintain compliance, manage supplier relationships, and leverage data-driven insights to make faster, more informed decisions.

Today, Scientist.com supports more than 130 life science organizations, including 24 of the world's top 30 pharmaceutical companies, helping teams reduce operational complexity, accelerate timelines, and bring innovations to patients faster. Our mission is to make it possible to cure all human disease by 2050.

Related Content

Related Content